Skip to main content
. 2023 Jan 11;16:1099019. doi: 10.3389/fnins.2022.1099019

TABLE 1.

Comparison of sex, age, and pathological grade between IDHmut/MGMTmet and the other glioma group.

Demographics IDHmut/MGMTmet, N = 40 Other molecular status (IDHwt/MGMTmet, n = 32; IDHmut/MGMTunmet, n = 1; IDHwt/MGMTunmet, n = 45), N = 78 P-value
Age (years) 49.03 ± 11.77 55.53 ± 11.44 0.005*
Sex [male, n (%)] 21 (52.5%) 41 (52.6%) 0.995
Grade, n (%)
Lower grade (II + III) 36 (90.0%) 12 (15.4%) <0.001*
Glioblastoma (IV) 4 (10.0%) 66 (84.6%)

*P < 0.05.